Paper · 305461
Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.
Lee SK and 1 other. J Exp Med, 1978. Cited by 68 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia. Papers, record 305461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/305461
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| T-Lymphocytes | Major topic |
| HLA Antigens | |
| Humans | |
| Isoantigens | |
| Lymphocyte Activation | |
| Lymphocyte Cooperation |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,139,934 | IMMUNOLOGY OF EXPERIMENTAL TUMORS. | Annu Rev Med | 1964 | https://conductscience.org/library/papers/14139934 | PubMed |
| 2 | 63,529 | Radiation leukemia in C57BL/6 mice. II. Lack of ecotropic virus expression in the majority of lymphomas. | J Exp Med | 1976 | https://conductscience.org/library/papers/63529 | PubMed |
| 3 | 63,528 | Radiation leukemia in C57BL/6 mice. I. Lack of serological evidence for the role of endogenous ecotropic viruses in pathogenesis. | J Exp Med | 1976 | https://conductscience.org/library/papers/63528 | PubMed |
| 4 | 322,689 | Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. | Br J Cancer | 1977 | https://conductscience.org/library/papers/322689 | PubMed |
| 5 | 1,086,826 | Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera. | Immunology | 1976 | https://conductscience.org/library/papers/1086826 | PubMed |
| 6 | 1,069,027 | Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro. | J Immunol | 1976 | https://conductscience.org/library/papers/1069027 | PubMed |
| 7 | 4,125,685 | Lymphocyte activation and destruction in vitro in relation to MLC and HL-A. | Transplant Proc | 1973 | https://conductscience.org/library/papers/4125685 | PubMed |
| 8 | 4,114,812 | Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer. | Br J Cancer | 1972 | https://conductscience.org/library/papers/4114812 | PubMed |
| 9 | 4,130,075 | The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man. | Transplant Proc | 1973 | https://conductscience.org/library/papers/4130075 | PubMed |
| 10 | 4,140,237 | Studies on specificity of cell-mediated immunity to human tumors. | J Natl Cancer Inst | 1974 | https://conductscience.org/library/papers/4140237 | PubMed |
1 to 10 of 24
See all 24 referencesCited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,774,361 | HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation. | Immunology | 1996 | https://conductscience.org/library/papers/8774361 | PubMed |
| 8,513,452 | Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8513452 | PubMed |
| 8,512,807 | Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8512807 | PubMed |
| 6,961,951 | Susceptibility of human leukaemias to cell-mediated cytotoxicity by interferon-treated allogeneic lymphocytes. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6961951 | PubMed |
| 6,764,836 | Specific adoptive immunotherapy: experimental basis and future potential. | Surv Immunol Res | 1982 | https://conductscience.org/library/papers/6764836 | PubMed |
| 6,626,451 | Treatment of fresh human leukaemia cells with actinomycin D enhances their lysability by natural killer cells. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6626451 | PubMed |
| 6,553,506 | The role of allogeneic cells in the stimulation of cell-mediated cytotoxicity to leukaemia cells. A family study. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6553506 | PubMed |
| 6,451,236 | In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6451236 | PubMed |
| 6,450,603 | In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6450603 | PubMed |
| 6,446,429 | Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/6446429 | PubMed |
1 to 10 of 23
See all 23 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/305461
GET https://conductscience.org/api/papers/v1/305461/references?page=2